Royal Bank of Canada
AMRI

Royal Bank of Canada’s Albany Molecular Research Inc AMRI Stock Holding History

Royal Bank of Canada’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,476
Closed -$748K – 7289
2017
Q2 		$748K Sell
34,476
-6,144
-15% -$112K ﹤0.01% 3340
2017
Q1 		$571K Sell
40,620
-3,320
-8% -$54.4K ﹤0.01% 3535
2016
Q4 		$825K Buy
43,940
+635
+1% +$10.8K ﹤0.01% 3314
2016
Q3 		$716K Sell
43,305
-1,148
-3% -$17K ﹤0.01% 3408
2016
Q2 		$597K Buy
44,453
+611
+1% +$8.91K ﹤0.01% 3547
2016
Q1 		$670K Buy
43,842
+7,568
+21% +$119K ﹤0.01% 3401
2015
Q4 		$719K Sell
36,274
-982
-3% -$18.7K ﹤0.01% 3425
2015
Q3 		$650K Buy
37,256
+1,808
+5% +$36.8K ﹤0.01% 3251
2015
Q2 		$717K Buy
35,448
+1,452
+4% +$28K ﹤0.01% 3223
2015
Q1 		$598K Buy
33,996
+1,096
+3% +$18.7K ﹤0.01% 3342
2014
Q4 		$536K Hold
32,900
– – ﹤0.01% 3483
2014
Q3 		$726K Sell
32,900
-260
-0.8% -$5.32K ﹤0.01% 3110
2014
Q2 		$667K Sell
33,160
-30
-0.1% -$508 ﹤0.01% 3177
2014
Q1 		$617K Buy
33,190
+1,640
+5% +$22.6K ﹤0.01% 3181
2013
Q4 		$318K Sell
31,550
-3,144
-9% -$38K ﹤0.01% 3775
2013
Q3 		$447K Buy
34,694
+594
+2% +$7.31K ﹤0.01% 3459
2013
Q2 		$405K Buy
+34,100
New +$369K ﹤0.01% 3334

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Royal Bank of Canada's AMRI Position: Q3 2017 in Review

Royal Bank of Canada sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 34,476 shares — an estimated $748K sold.

Royal Bank of Canada first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $825K in Q4 2016. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Royal Bank of Canada reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Royal Bank of Canada sold 34,476 Albany Molecular Research Inc shares in Q3 2017, an estimated $748K.
  • Royal Bank of Canada first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Royal Bank of Canada's Albany Molecular Research Inc position peaked at $825K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Royal Bank of Canada's 13F filing for Q3 2017, filed 14 Nov 2017.